Related references
Note: Only part of the references are listed.Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations
E. David Crawford et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2019)
Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies
Eleanor L. Watts et al.
EUROPEAN UROLOGY (2018)
A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts
Elizabeth A. Platz et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations
Michael B. Cook et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial
Jeannette M. Schenk et al.
CANCER CAUSES & CONTROL (2016)
Sex differences in immune responses
Sabra L. Klein et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial
Sarah H. Nash et al.
CANCER PREVENTION RESEARCH (2015)
Intraprostatic inflammation is positively associated with serum PSA in men with PSA < 4 ng ml-1, normal DRE and negative for prostate cancer
M. H. Umbehr et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2015)
Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial
Bora Gurel et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Association between endogenous sex steroid hormones and inflammatory biomarkers in US men
K. K. Tsilidis et al.
ANDROLOGY (2013)
Associations of Serum Sex Steroid Hormone and 5α-Androstane-3α, 17β-Diol Glucuronide Concentrations with Prostate Cancer Risk Among Men Treated with Finasteride
Alan R. Kristal et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study
Song Yao et al.
CANCER CAUSES & CONTROL (2011)
Body fatness and sex steroid hormone concentrations in US men: results from NHANES III
Sabine Rohrmann et al.
CANCER CAUSES & CONTROL (2011)
The prevalence of low sex steroid hormone concentrations in men in the Third National Health and Nutrition Examination Survey (NHANES III)
Sabine Rohrmann et al.
CLINICAL ENDOCRINOLOGY (2011)
Estrogen action and prostate cancer
Jason L. Nelles et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2011)
Potential mechanisms of estrogen quinone carcinogenesis
Judy L. Bolton et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies
Andrew W. Roddam et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Inflammation in prostate carcinogenesis
Angelo M. De Marzo et al.
NATURE REVIEWS CANCER (2007)
The influence of finasteride on the development of prostate cancer
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
